Non-Small Cell Lung Cancer (NSCLC)-Dynamic Market 2018-2025 : Dynamic Market Forecast include - Regulatory filings, Approval decisions, Pricing changes, Patent litigation

ResearchMoz presents Professional and In-depth Study of "Non-Small Cell Lung Cancer (NSCLC)-Dynamic Market Forecast to 2025" with coming years Industries Trends, Projections of Global Growth, Major Key Player and Case Study, Review, Share, Size, Effect.
' '
The NSCLC therapeutics market is a rapidly evolving field in which new developments are constantly influencing the landscape. The Forecast Update is designed to help clients stay abreast of the latest news in the NSCLC space, including regulatory, commercial, and clinical events, and to understand how these events will impact the market forecast.

Scope

Key events covered in the Dynamic Market Forecast include -
- Regulatory filings
- Approval decisions
- Pricing changes
- Patent litigation
- Clinical trial data announcements
- Clinical trial failures
- Clinical trial timeline updates
. .
– Get Sample Report_ https://www.researchmoz.us/enquiry.php?type=S&repid=1641340
' '
Components of the slide deck include : -
- Timeline of market-impacting events
- Key clinical trial landscape updates
- Detailed analysis of the most impactful events, including new primary research to gain Key Opinion Leader perspective
- Overview of updates to the forecast model based on anticipated future impact of events
- Forward-looking events calendar listing expected key updates to the NSCLC competitive space in the next quarter

Reasons to buy:

- Recent regulatory events
- Recent commercial events
- Recent clinical events
- Market dynamics in the frontline NSCLC setting
- Landscape changes in the EGFR-mutant NSCLC setting
- Projected treatment algorithm shifts in the ALK-mutant NSCLC setting
. .
– More Clear Details get Full Table of Contents_https://www.researchmoz.us/non-small-cell-lung-cancer-nsclc-dynamic-market-forecast-to-2025-report.html/toc
' '
Table of Contents

1. Dynamic Market Forecast Overview 5
1.1 Related Reports 6
1.2 Upcoming Related Reports 7
2. Executive Summary 8
2.1 Key Events in Update 9-10
2.2 Updates to Treatment Algorithms 11
2.3 Clinical Trial Landscape Updates 12-13
2.4 Pipeline Landscape Updates 14
2.5 Market Insight on Key Events 15
3. Event 1: Market Dynamics Shift in Frontline NSCLC 16
3.1 Key Updates to the Frontline Non-squamous Setting 17
3.2 Merck & Co., Keytruda (pembrolizumab) 18-19
3.3 AstraZeneca, Imfinzi (durvalumab) + tremelimumab 20-21
3.4 Pfizer and Merck KGaA , Bavencio (avelumab) 22
3.5 Roche, Tecentriq (atezolizumab) 23
3.6 Novartis, Tafinlar (dabrafenib) + Mekinist (trametinib) 24
3.7 Additional Clinical Trial Updates- Frontline Setting 25-26
3.8 Summary/Trends 27
3.9 Sources 28
4. Event 2: Weak Competition in the EGFRm+ Segment Creates Opportunity for Tagrisso 29
4.1 Key Updates to the EGFRm+ Segment 30
4.2 AstraZeneca, Tagrisso (osimertinib) 31-33
4.3 Pfizer, dacomitinib 34
4.4 Additional Clinical Trial Updates- EGFRm+ Setting 35
4.5 Summary/Trends 36
4.6 Sources 37
5. Event 3: New SOC Anticipated in the ALKm+ 1L Setting 38
5.1 Key Updates to the ALKm+ Setting 39
5.2 Roche, Alecensa (alectinib) 40
5.3 Takeda, Alunbrig (brigatinib) 41
5.4 Pfizer, lorlatinib 42
5.5 Summary/Trends 43
5.6 Sources 44
6. Other Events of Interest 45
6.1 Various Developers 46-47
6.2 Sources 48
7. Dynamic Market Forecast Highlights 49

Continue.....01 Nov 18
https://www.researchmoz.us/non-small-cell-lung-cancer-nsclc-dynamic-market-forecast-to-2025-report.html

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
sales@researchmoz.us
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.